Clinical trials
Phase 1 Fibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
69 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 4 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 4 |
| 2016 | 5 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 6 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 5 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 40 |
| Unknown status | 11 |
| Recruiting | 7 |
| Terminated | 7 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 3 |
| Anhui Provincial Hospital | 2 |
| Blade Therapeutics | 2 |
| GlaxoSmithKline | 2 |
| M.D. Anderson Cancer Center | 2 |
| National Cancer Institute (NCI) | 2 |
| National Center for Research Resources (NCRR) | 2 |
| RXi Pharmaceuticals, Corp. | 2 |
| Virginia Commonwealth University | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fibrosis | 69 |
| Liver Cirrhosis | 8 |
| Carcinoma, Hepatocellular | 5 |
| Cicatrix | 5 |
| Idiopathic Pulmonary Fibrosis | 5 |
| Hepatitis C | 4 |
| Hepatic Encephalopathy | 3 |
| Keloid | 3 |
| Liver Diseases | 3 |
| Lung Diseases | 3 |
Trials
Showing 51 to 69 of 69. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.